• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    1/14/22 12:22:28 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care
    Get the next $DYNT alert in real time by email
    SC 13G/A 1 dynt_sc13ga.htm SC 13G/A dynt_sc13ga.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No.1)*

     

    Dynatronics Corporation

    (Name of Issuer)

     

    Common Stock, no par value

    (Title of Class of Securities)

     

    268157

    (CUSIP Number)

     

    July 27, 2021

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)

     

    ☒ Rule 13d-1(c)

     

    ☐ Rule 13d-1(d)

    __________

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    CUSIP No

    268157

     

        

    1.

    NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Nancy K. Cronin

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

    (a) ☐

    (b) ☐

    3.

    SEC USE ONLY

     

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    USA

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5.

    SOLE VOTING POWER

     

    824,041

    6.

    SHARED VOTING POWER

     

    0

    7.

    SOLE DISPOSITIVE POWER

     

    824,041

    8.

    SHARED DISPOSITIVE POWER

     

    0

     

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    824,041

    10.

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

    ☐

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    4.7%

    12.

    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

    IN

     

     
    2

     

     

    CUSIP No

    268157

     

        

    Item 1.

    (a).

    Name of Issuer:

     

     

     

     

     

    Dynatronics Corporation

     

     

     

     

    (b).

    Address of Issuer's Principal Executive Offices:

     

     

     

     

     

    1200 Trapp Road

    Eagan, Minnesota 55121

     

     

     

    Item 2.

    (a).

    Name of Person Filing:

     

     

     

     

     

    Nancy K. Cronin

     

     

     

     

    (b).

    Address of Principal Business Office, or if None, Residence:

     

     

     

     

     

    Nancy K. Cronin

    6101 Mt. Normandale Drive

    Bloomington, Minnesota 55438

    United States of America

     

     

     

     

    (c)

    Citizenship:

     

     

     

     

     

    United States of America

     

     

     

     

    (d).

    Title of Class of Securities:

     

     

     

     

     

    Common Stock

     

     

     

     

    (e).

    CUSIP Number:

     

     

     

     

     

    268157

     

    Item 3.

     

    If This Statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a

     

     

     

     

     

    (a)

    ☐

    Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78c).

     

     

     

     

     

    (b)

    ☐

    Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).

     

     

     

     

     

    (c)

    ☐

    Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).

     

     

     

     

     

    (d)

    ☐

    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

     

     
    3

     

     

     

    (e)

    ☐

    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

     

     

     

     

    (f)

    ☐

    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

     

     

     

     

    (g)

    ☐

    A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

     

     

     

     

    (h)

    ☐

    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

     

     

     

     

    (i)

    ☐

    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

     

     

     

     

    (j)

    ☐

    Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

     

    Item 4.

    Ownership.

     

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

     

     

    (a)

    Amount beneficially owned:

     

     

     

     

     

    824,041 shares

     

    All of the shares reported as beneficially owned by Nancy K. Cronin are held by the Nancy K. Cronin Revocable Trust.

     

     

     

     

    (b)

    Percent of class:

     

     

     

     

     

    4.7%

     

     

     

     

    (c)

    Number of shares as to which the person has:

     

     

     

     

     

    (i)

    Sole power to vote or to direct the vote

     

     

     

     

     

     

    824,041

     

     

     

     

    (ii)

    Shared power to vote or to direct the vote

     

     

     

     

     

     

    0

     

     

     

     

    (iii)

    Sole power to dispose or to direct the disposition of

     

     

     

     

     

     

    824,041

     

     

     

     

    (iv)

    Shared power to dispose or to direct the disposition of

     

     

     

     

     

     

    0

     

     

     
    4

     

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

     

     

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6.

    Ownership of More Than Five Percent on Behalf of Another Person.

     

     

     

    N/A

     

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

     

     

    If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

     

     

    N/A

     

     

    Item 8.

    Identification and Classification of Members of the Group.

     

     

     

    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.

     

     

    N/A

     

    Item 9.

    Notice of Dissolution of Group.

     

     

     

    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.

     

     

    N/A

     

     

    Item 10.

    Certification.

     

     

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     
    5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

     

    January 7, 2022

     

     

    (Date)

     

     

     

    /s/ Nancy K. Cronin

     

     

    Nancy K. Cronin

     

     

     
    6

     

     

    Exhibit A

     

    AGREEMENT

     

    The undersigned agree that this Schedule 13G Amendment No. 1 dated January 7, 2022 relating to the Common Stock of Dynatronics Corporation shall be filed on behalf of the undersigned.

     

     

    /s/ Nancy K. Cronin

     

     

    Nancy K. Cronin

     

     

     
    7

     

    Get the next $DYNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DYNT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DYNT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Dynatronics Corporation

      10-Q - DYNATRONICS CORP (0000720875) (Filer)

      5/12/25 4:00:27 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      5/9/25 8:00:26 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation filed SEC Form 8-K: Leadership Update

      8-K - DYNATRONICS CORP (0000720875) (Filer)

      4/18/25 7:30:18 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Leadership Updates

    Live Leadership Updates

    See more
    • Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

      Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

      1/8/24 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Appointment of Dr. Christopher von Jako as new CEO

      Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

      6/21/23 9:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

      Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

      5/18/23 8:05:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

      Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

      1/8/24 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Appointment of Dr. Christopher von Jako as new CEO

      Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

      6/21/23 9:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

      Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

      5/18/23 8:05:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Financials

    Live finance-specific insights

    See more
    • Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

      Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

      5/11/23 7:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

      Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

      4/27/23 8:00:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

      EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

      2/9/23 7:30:00 AM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/14/23 12:35:29 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      2/13/23 12:33:51 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

      SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

      1/14/22 12:22:28 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care

    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Staats Ryan Edward claimed ownership of 40 shares (SEC Form 3)

      3 - DYNATRONICS CORP (0000720875) (Issuer)

      5/12/25 4:00:53 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Director Enright Erin S. acquired 739,014 shares (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:12:03 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care
    • Large owner Provco Ventures 1 Lp acquired 369,292 shares, increasing direct ownership by 29% to 1,633,439 units (SEC Form 4)

      4 - DYNATRONICS CORP (0000720875) (Issuer)

      4/3/25 3:10:57 PM ET
      $DYNT
      Medical/Dental Instruments
      Health Care